Cargando…

Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma

BACKGROUND: Neurovascular-related genes have been implicated in the development of cancer. Studies have shown that a high expression of neuropilins (NRPs) promotes tumourigenesis and tumour malignancy. METHOD: A multidimensional bioinformatics analysis was performed to examine the relationship betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Chao, Guo, Hang, Yan, Dongliang, Liang, Tao, Ye, Xuxiao, Li, Zuowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062179/ https://www.ncbi.nlm.nih.gov/pubmed/33937395 http://dx.doi.org/10.1155/2021/5546612

Ejemplares similares

NRP1 function and targeting in neurovascular development and eye disease
por: Raimondi, Claudio, et al.
Publicado: (2016)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
por: Xiong, Ye, et al.
Publicado: (2022)

FAM46B Promotes Apoptosis and Inhibits Glycolysis of Prostate Cancer Through Inhibition of the MYC-LDHA Axis
por: Liang, Tao, et al.
Publicado: (2020)

CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023)

Segregation Analysis of Rare NRP1 and NRP2 Variants in Families with Lymphedema
por: Michelini, Sandro, et al.
Publicado: (2020)

MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Role of NRP1 in Bladder Cancer Pathogenesis and Progression
por: Dong, Yang, et al.
Publicado: (2021)

Pancancer Analysis of the Prognostic and Immunotherapeutic Value of Progestin and AdipoQ Receptor 4
por: Yang, Ziyue, et al.
Publicado: (2022)

Corrigendum: MXD3 as an Immunological and Prognostic Factor From Pancancer Analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2021)

Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer
por: Schulz, Alexander, et al.
Publicado: (2020)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
por: Zhou, Lingyi, et al.
Publicado: (2022)

Diagnostic, Prognostic, and Immunological Roles of FABP4 in Pancancer: A Bioinformatics Analysis
por: Yang, Jing, et al.
Publicado: (2022)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma
por: Guo, Ya, et al.
Publicado: (2022)

PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
por: Ni, Wenpeng, et al.
Publicado: (2023)

Expression of NRP-1 and NRP-2 in Endometrial Cancer
por: Oplawski, Marcin, et al.
Publicado: (2019)

Independent prognostic miRNAs for bladder urothelial carcinoma
por: Hu, Yingbo, et al.
Publicado: (2017)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Pancancer survival analysis of cancer hallmark genes
por: Nagy, Ádám, et al.
Publicado: (2021)

Down-Regulation of Nfatc1 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Prostate Cancer Cells
por: Liu, Yuanyuan, et al.
Publicado: (2019)

FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin
por: Liang, Tao, et al.
Publicado: (2018)

A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors
por: Wu, Yunhui, et al.
Publicado: (2022)

Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
por: Male, Musa, et al.
Publicado: (2019)

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder
por: Kucuk, Ulku, et al.
Publicado: (2015)

Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
por: Yu, Shian, et al.
Publicado: (2023)

Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients
por: Mohanad, Marwa, et al.
Publicado: (2022)

KDELR2 as a diagnostic and prognostic biomarker of bladder urothelial carcinoma and its correlation with immune infiltration
por: Ma, Sai, et al.
Publicado: (2023)

Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors
por: Li, Yuan, et al.
Publicado: (2020)

Pancancer Analysis of the Oncogenic and Prognostic Role of NOL7: A Potential Target for Carcinogenesis and Survival
por: Liu, Qiaojun, et al.
Publicado: (2022)

Deep learning with multimodal representation for pancancer prognosis prediction
por: Cheerla, Anika, et al.
Publicado: (2019)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle
por: Jiang, Yi, et al.
Publicado: (2023)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression
por: Dong, Yang, et al.
Publicado: (2022)

Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
por: Meireles, Sara, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
por: Chen, Chen, et al.
Publicado: (2022)

Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_td9nf4dn9v0b176eej1rk3snle